Obesity is increasing in the pediatric population and it represents an important risk factor for the life-long development of several diseases. The aim of this work is to reduce children obesity through an educational program delivered through a mobile application. Novelties of our approach are the involvement of the families in the program and a design inspired to psychological/behavioral change theories, with the aim of maximizing the chance of patients' compliance to the program. A pilot usability and acceptability study has been performed on ten children aged 6-12 years using a questionnaire to evaluate eight system features on a Likert scale from 1 to 5. Encouraging results were obtained: mean scores were all above 3.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3233/SHTI230317 | DOI Listing |
Nutr Metab (Lond)
January 2025
Shenzhen Center for Chronic Disease Control, No. 2021 Buxin Road, Luohu District, Shenzhen, 518020, China.
Background: Serum vitamin D deficiency is intricately linked to metabolic disorders, however, evidence on its association with continuous metabolic risk in children and adolescents remains insufficient. This study aims to elucidate the relationship between serum vitamin D levels and continuous metabolic risk.
Methods: The cross-sectional analysis involved 4490 participants aged 6 ~ 18, and the longitudinal investigation included 1398 individuals aged 6 ~ 12 years.
BMC Public Health
January 2025
School of Public Health, North Sichuan Medical College, No. 234 Fujiang Road, Nanchong, 637000, Sichuan, China.
Background: Childhood obesity is associated with obesity in adulthood, but the consistency between the geographic distributions of obesity among children and adults in China is not fully understood. We aimed to examine the consistency of the geographic distributions of overweight and obesity between adults and children in China.
Methods: This was a cross-sectional study including 11,940 adults.
Clinical trials demonstrate the short-term efficacy of dual CFTR modulators, but long-term real-world data is limited. We aimed to investigate the effects of 24-month lumacaftor/ivacaftor (LUM/IVA) therapy in pediatric CF patients (pwCF). This observational study included pwCF homozygous for F508del mutation treated between 2021 and 2023.
View Article and Find Full Text PDFLancet Diabetes Endocrinol
January 2025
Division of Diabetes & Nutritional Sciences, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK; Catholic University of the Sacred Heart, Rome, Italy; University Polyclinic Foundation Agostino Gemelli IRCCS, Rome, Italy.
Pediatr Obes
January 2025
Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Objective: Conduct a systematic review and meta-analysis of randomized controlled trials (RCTs) of behavioural and psychological interventions for managing paediatric obesity.
Methods: Eligible studies, published between 1985 and 2022, included 0 to 18 year olds with outcomes reported ≥3 months post-baseline, including patient-reported outcome measures (PROMs), cardiometabolic and anthropometric outcomes, and adverse events (AEs). We pooled data using a random effects model and assessed certainty of evidence (CoE) related to minimally important difference estimates for outcomes using GRADE.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!